Balfour Beatty (LON:BBY – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Jefferies Financial Group in a report released on Wednesday, Digital Look reports. They currently have a GBX 1,120 price objective on the stock. Jefferies Financial Group’s price objective points to a potential upside of 33.73% from the stock’s current price.
Several other equities research analysts have also commented on BBY. Deutsche Bank Aktiengesellschaft raised their price target on shares of Balfour Beatty from GBX 990 to GBX 1,100 and gave the company a “buy” rating in a research note on Wednesday, August 12th. Berenberg Bank lifted their price target on Balfour Beatty from GBX 870 to GBX 1,070 and gave the company a “buy” rating in a report on Thursday, August 13th. Three analysts have rated the stock with a Buy rating. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of GBX 1,096.67.
Balfour Beatty Stock Performance
Balfour Beatty (LON:BBY – Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The company reported GBX 21.70 earnings per share for the quarter. Balfour Beatty had a net margin of 2.60% and a return on equity of 22.88%. As a group, equities analysts forecast that Balfour Beatty will post 43.31 earnings per share for the current year.
About Balfour Beatty
Balfour Beatty is a leading international infrastructure group. With 26,000 employees across the UK, US and Hong Kong, we’re leading the transformation of our industry to meet the challenges of the future.
Trusted by our customers to deliver sustainable solutions and strengthen communities, we finance, develop, build, maintain and operate the increasingly complex and critical infrastructure that supports national economies and deliver projects at the heart of local communities.
Collaborating with governments, our customers and partners, we deliver powerful new solutions, shape thinking, create skylines and inspire a new generation of talent to be the change-makers of tomorrow.
Read More
- Five stocks we like better than Balfour Beatty
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
- Albertsons Is Betting on a Turnaround—But Will It Pay Off?
- Venezuela’s Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit
- PepsiCo’s Earnings Beat Masks a Bigger Problem With Its North American Business
Receive News & Ratings for Balfour Beatty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balfour Beatty and related companies with MarketBeat.com's FREE daily email newsletter.
